{"id":13841,"date":"2026-06-11T00:04:51","date_gmt":"2026-06-11T00:04:51","guid":{"rendered":"https:\/\/medical-article.com\/?p=13841"},"modified":"2026-06-11T00:04:51","modified_gmt":"2026-06-11T00:04:51","slug":"the-long-and-winding-road-75-years-of-competition-in-health-care-policy","status":"publish","type":"post","link":"https:\/\/medical-article.com\/?p=13841","title":{"rendered":"The Long and Winding Road: 75 Years of Competition in Health Care Policy"},"content":{"rendered":"<p>When health economics emerged as a distinct discipline in the late 1960s, mainstream academic and policy paradigms widely presumed that competitive market mechanisms were structurally incompatible with medical delivery. Influenced by foundational ideas like <a href=\"https:\/\/assets.aeaweb.org\/asset-server\/files\/9442.pdf\">Kenneth Arrow\u2019s 1963<\/a> landmark paper emphasizing the pervasive friction of clinical uncertainty, early experts argued that society had to look almost exclusively to non-market interventions to fix systematic gaps in medical equity and insurance. Over the subsequent half-century, however, intellectual paradigms underwent a profound shift from command-and-control regulation toward various nuanced forms of market competition. In a interesting retrospective, <a href=\"https:\/\/www.aeaweb.org\/articles?id=10.1257\/jep.20251470\">Paul Ginsburg (2026)<\/a> traces this 75-year evolution, mapping out how the policy landscape moved from strict administrative pricing toward the complex paradigm of managed competition.  <\/p>\n<p>Below is a breakdown of the key historical themes and regulatory shifts discussed in the article:<\/p>\n<p><strong>Hospital Price Regulation:<\/strong> During the 1970s, rapidly rising costs drove federal and state regulators to experiment with direct rate-setting, transitioning from paying passive \u201creasonable costs\u201d to imposing strict daily limits and state-level, all-payer prospective rate systems. This administrative experiment culminated in Medicare\u2019s 1983 adoption of national diagnosis-related groups (DRGs), which created artificial competitive incentives by allowing lower-cost hospitals to retain financial surpluses.  <strong>Supply Restrictions:<\/strong> Believing in \u201c<a href=\"https:\/\/en.wikipedia.org\/wiki\/Roemer%27s_law\">Roemer\u2019s Law<\/a>\u201c\u2014the mid-century notion that an expansion of hospital bed capacity automatically generates its own utilization demand\u2014the federal government and individual states actively curbed market entry via Certificate of Need (CON) laws. Despite systematic research later demonstrating that CON mandates have had no measurable long-term impact on containing total expenditures, 35 programs remain active, largely serving to insulate incumbent health systems from direct competitive entry.  <strong>Antitrust Policy:<\/strong> Antitrust enforcement remained entirely absent in the health sector for decades because courts and federal agencies long presumed that nonprofit and charitable medical entities would not act to aggressively raise market rates. This regulatory paradigm was broken by landmark legal benchmarks, starting with the <a href=\"https:\/\/en.wikipedia.org\/wiki\/Goldfarb_v._Virginia_State_Bar\">1975 <\/a><em><a href=\"https:\/\/en.wikipedia.org\/wiki\/Goldfarb_v._Virginia_State_Bar\">Goldfarb<\/a><\/em><a href=\"https:\/\/en.wikipedia.org\/wiki\/Goldfarb_v._Virginia_State_Bar\"> decision<\/a> ruling that professions are subject to the <a href=\"https:\/\/en.wikipedia.org\/wiki\/Sherman_Antitrust_Act\">Sherman Antitrust Act<\/a>, and culminating in the FTC\u2019s pivotal 2007 <em><a href=\"https:\/\/www.ftc.gov\/legal-library\/browse\/cases-proceedings\/0110234-evanston-northwestern-healthcare-corporation-enh-medical-group-inc\">Evanston Northwestern<\/a><\/em><a href=\"https:\/\/www.ftc.gov\/legal-library\/browse\/cases-proceedings\/0110234-evanston-northwestern-healthcare-corporation-enh-medical-group-inc\"> <\/a>victory that halted a multi-decade streak of failed non-profit merger challenges.  <strong>Initial Steps Towards Fostering Competition:<\/strong> The federal government first attempted to explicitly inject market forces into the sector via the Health Maintenance Organization (HMO) Act of 1973, which provided direct developmental grants and mandated that employers offer integrated financing-and-delivery options. While inspired by integrated paradigms like Kaiser Permanente, many people believe modern HMOs largely are mechanisms for restrictive insurance plan architectures rather than fundamentally reorganized delivery models.  <strong>Managed Competition Frameworks:<\/strong> Popularized by Alain Enthoven\u2019s influential late-1970s conceptual models, this paradigm proposed that insurers compete on transparent premiums within structured marketplaces backed by fixed employer contributions. These ideas directly shaped the competitive architecture of modern state-run Affordable Care Act (ACA) Marketplace exchanges, and also have been adapted internationally (e.g., Germany, Netherlands, Switzerland).<strong>The Evolution of Managed Care:<\/strong> To curb persistent spending growth driven by provider moral hazard, employer-sponsored plans transitioned away from passive, fee-for-service bill indemnification toward highly structured managed care products like PPOs and HMOs. These network models have evolved to use precise, highly restrictive cost-containment tools, utilizing aggressive financial incentives to keep care in-network alongside non-financial hurdles like prior authorization.  <strong>Public Program Market Integration:<\/strong> Federal and state authorities have increasingly woven competitive designs directly into public entitlements, creating multi-billion dollar markets via Medicare Advantage and Medicaid managed care programs. While Medicare Advantage has expanded to capture more than half of all eligible beneficiaries by 2026, an ongoing policy challenge remains the reality that plan payments are inflated by favorable selection rather than pure cost efficiency.  <strong>Medicare Physician Payment Reform:<\/strong> In 1989, Congress completely overhauled medical reimbursement by implementing a comprehensive, resource-based relative value scale (RBRVS) fee schedule to rectify severe imbalances between procedural interventions and cognitive primary care visits. This administrative pricing standard\u2013initially proposed by <a href=\"https:\/\/www.nejm.org\/doi\/abs\/10.1056\/NEJM198809293191305\">Hsiao et al. 1988<\/a>\u2014 was quickly adopted by commercial insurers, effectively establishing a unified national baseline that simplified corporate provider negotiations into clean percentages of the Medicare benchmark.  <strong>Price and Quality Transparency:<\/strong> Hoping to empower consumers to act as price-sensitive shoppers for routine services, recent federal regulations have forced hospitals and commercial insurers to publicly report their negotiated contract rates. However, consumer engagement remains low because navigating complex clinical data under illness is exceptionally difficult.  Moreover, price transparency paradoxically can raise prices in this environment, if consumers are not price sensitive and low-cost providers realize they can raise prices to the local average. <strong>Fostering Rational Consumer Choices:<\/strong> Drawing heavily on behavioral economics and the \u201cparadox of choice,\u201d modern state exchanges like Covered California have standardized benefit levels and intentionally restricted the number of regional plan offerings to optimize consumer decision-making. These structural boundaries mitigate systemic consumer biases, such as the tendency to overvalue low-deductible copay coverage at the expense of necessary, long-term catastrophic protection.  <strong>Recent Antitrust Challenges:<\/strong> The modern consolidation wave across hospital systems, physician practices, and commercial insurers has forced federal regulators to pivot from traditional horizontal merger reviews toward complex vertical and cross-market integration. This includes investigating the potential for competitive distortions arising from arbitrary site-neutral payment rules, which allow hospital-owned outpatient departments to extract higher facility fees than independent doctors, accelerating the corporate acquisition of independent practices.  <strong>The Public Option and Cost Growth Targets:<\/strong> Frustrated by high commercial insurance premiums, states like Washington and Colorado have launched targeted \u201cpublic option\u201d plans that contract with private administrators while mandating lower provider reimbursement baselines.  <\/p>\n<p>As Ginsburg concludes, the contemporary American healthcare system remains far removed from any textbook model of perfect competition. Yet, competitive market dynamics undeniably serve as a core structural element governing the modern landscape. The article concludes by noting that competition\u2013particularly in highly regulated markets with third-party payers\u2013has both pros and cons: <\/p>\n<p>Economists are deeply familiar with the idea that competition is a two-edged set of incentives, especially in markets characterized by imperfect information and imperfect competition. On one side, the incentives of competition can encourage providers to provide lower costs and higher quality; on the other side, they can encourage providers to game the competitive mechanisms design to create such a market or cut costs by limiting access to care.<\/p>\n<p>The article is great overview and is the initial article in the <em><a href=\"https:\/\/www.aeaweb.org\/issues\/846?to=19551\">Journal of Economics Perspectives<\/a><\/em><a href=\"https:\/\/www.aeaweb.org\/issues\/846?to=19551\"> special issue on competition in health care<\/a>.<\/p>","protected":false},"excerpt":{"rendered":"<p>When health economics emerged as a distinct discipline in the late 1960s, mainstream academic and policy paradigms widely presumed that competitive market mechanisms were structurally incompatible with medical delivery. Influenced by foundational ideas like Kenneth Arrow\u2019s 1963 landmark paper emphasizing the pervasive friction of clinical uncertainty, early experts argued that society had to look almost&#8230;<\/p>\n","protected":false},"author":0,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2],"tags":[],"class_list":["post-13841","post","type-post","status-publish","format-standard","hentry","category-articles"],"_links":{"self":[{"href":"https:\/\/medical-article.com\/index.php?rest_route=\/wp\/v2\/posts\/13841"}],"collection":[{"href":"https:\/\/medical-article.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medical-article.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/medical-article.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=13841"}],"version-history":[{"count":0,"href":"https:\/\/medical-article.com\/index.php?rest_route=\/wp\/v2\/posts\/13841\/revisions"}],"wp:attachment":[{"href":"https:\/\/medical-article.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=13841"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medical-article.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=13841"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medical-article.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=13841"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}